ArticleFuture oncology (London, England)2026

The integrated 31-gene expression profile test identifies low-risk patients with cutaneous melanoma who can forego the SLNB procedure: results from a prospective, multicenter trial.

Timothy Beard et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.